<SEC-DOCUMENT>0001213900-22-052615.txt : 20220831
<SEC-HEADER>0001213900-22-052615.hdr.sgml : 20220831
<ACCEPTANCE-DATETIME>20220831152013
ACCESSION NUMBER:		0001213900-22-052615
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20220831
DATE AS OF CHANGE:		20220831

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CREDIT SUISSE AG
		CENTRAL INDEX KEY:			0001053092
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-238458-02
		FILM NUMBER:		221217810

	BUSINESS ADDRESS:	
		STREET 1:		PARADEPLATZ 8
		CITY:			ZURICH
		STATE:			V8
		ZIP:			8001
		BUSINESS PHONE:		01141 44 333 1111

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 1
		CITY:			ZURICH
		STATE:			V8
		ZIP:			8070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CREDIT SUISSE / /FI
		DATE OF NAME CHANGE:	20050607

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CREDIT SUISSE FIRST BOSTON /                            /FI
		DATE OF NAME CHANGE:	19980115
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>s141723_424b2.htm
<DESCRIPTION>PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: red">The information in this preliminary pricing
supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell these securities and it is
not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; text-align: center; color: red"><B>Subject to completion dated August
31, 2022.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Arial, Helvetica, Sans-Serif">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 61%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>Preliminary Pricing Supplement No. G380</B><BR>
    To the Underlying Performance Supplement dated August 23, 2022,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Underlying Supplement dated June 18, 2020,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Product Supplement No. I&#8211;G dated February 4, 2022,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Prospectus Supplement dated June 18, 2020 and</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Prospectus dated June 18, 2020</P></TD>
    <TD STYLE="width: 39%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Filed Pursuant to Rule&nbsp;424(b)(2)<BR>
Registration Statement No. 333-238458-02<BR>
August 31, 2022 </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Arial, Helvetica, Sans-Serif">
  <TR>
    <TD STYLE="padding-right: 5pt; background-color: rgb(31,73,125); width: 14%; padding-left: 5pt">
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 10.1pt; text-indent: -10.1pt; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Financial</B></FONT></P>
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Products</B></FONT></P></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 85%; font-size: 10pt; vertical-align: middle"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><IMG SRC="image_001.jpg" ALT="CS_Solid_RGB (3)" STYLE="height: 63px; width: 147px"></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #004E78"><B>$</B></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #004E78"><B>CS Notes due September 30, 2027<BR>
Linked to the Performance of the Credit Suisse US Balanced 5% ER Index</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>Investors will not receive any interest or dividend payments.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>The securities are linked to the Credit Suisse US Balanced 5% ER Index (the &#8220;Underlying&#8221;)</B>, which is designed to
provide exposure to a hypothetical &#8220;balanced&#8221; portfolio while targeting a realized daily volatility of 5%. By &#8220;balanced&#8221;
we mean the Underlying&#8217;s hypothetical portfolio may, under certain circumstances include both:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#8226;</TD><TD STYLE="text-align: left"><B>equity exposure</B>, in the form of large-cap U.S. equities
included in the Credit Suisse US Equity Futures Index &#9;(&#8220;Equity Index&#8221;) described in this pricing supplement and the accompanying
underlying supplement; and</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#8226;</TD><TD STYLE="text-align: left"><B>fixed income exposure</B>, in the form of U.S. Treasury
note futures contracts tracked by the Fixed Income Indices described in this pricing supplement and the accompanying underlying supplement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in"><B>&#8220;Balanced&#8221; does not imply any risk adjusted diversified
asset class allocation or actual balance among asset classes.</B> See &#8220;Selected Risk Considerations&#8212; Risks Relating to the
Underlying&#8221; herein and &#8220;Selected Risk Considerations&#8221; in the accompanying underlying supplement.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>If the Final Level is greater than the Initial Level, investors will receive the principal amount of their investment plus a return
based on the leveraged upside performance of the Underlying. If the Final Level is equal to or less than the Initial Level, investors
will receive the principal amount of their investment.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>Senior unsecured obligations of Credit Suisse maturing September 30, 2027. Any payment on the securities is subject to our ability
to pay our obligations as they become due.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>Minimum purchase of $1,000. Minimum denominations of $1,000 and integral multiples of $1,000 in excess thereof.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>The offering price for the securities is expected to be determined on or about September 27, 2022 (the &#8220;Trade Date&#8221;),
and the securities are expected to settle on or about September 30, 2022 (the &#8220;Settlement Date&#8221;). Delivery of the securities
in book-entry form only will be made through The Depository Trust Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>The securities will not be listed on any exchange.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0 0"><B>Investing in the securities involves a number of risks. See &#8220;Selected
Risk Considerations&#8221; beginning on page 5 of this pricing supplement and &#8220;Risk Factors&#8221; beginning on page&nbsp;PS-3 of
the accompanying product supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0 0">Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of the securities or passed upon the accuracy or the adequacy of this pricing supplement, the accompanying
underlying supplement, the accompanying underlying performance supplement, the accompanying product supplement, the prospectus supplement
or the prospectus. Any representation to the contrary is a criminal offense.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 17%; border: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 21%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Price to Public<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 43%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Underwriting Discounts and Commissions<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Proceeds to Issuer</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 0.05in; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Per security</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$1,000</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 0.05in; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0">(1) Certain fiduciary accounts may pay a purchase price of at least
$962.50 per $1,000 principal amount of securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0">(2) We or any agent (one of which may be our affiliate) may pay varying
discounts and commissions of up to $37.50 per $1,000 principal amount of securities. CSSU or another broker or dealer will forgo some
or all discounts and commissions with respect to the sales of securities into certain fiduciary accounts. For more detailed information,
please see &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0">Credit Suisse Securities (USA)&nbsp;LLC (&#8220;CSSU&#8221;) is our
affiliate. For more information, see &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0"><B>Credit Suisse currently estimates the value of each $1,000
principal amount of the securities on the Trade Date will be between $920 and $960 (as determined by reference to our pricing models
and the rate we are currently paying to borrow funds through issuance of the securities (our &#8220;internal funding rate&#8221;)).
This range of estimated values reflects terms that are not yet fixed. A single estimated value reflecting final terms will be
determined on the Trade Date. See &#8220;Selected Risk Considerations&#8221; in this pricing supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><I>The securities are not deposit liabilities and are not insured or guaranteed
by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.</I></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><B>Credit Suisse</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">September&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2022</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 3pt; color: #004E78"><B>Key Terms</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Issuer:</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Credit Suisse AG (&#8220;Credit Suisse&#8221;), acting through its London branch.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Underlying:</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The securities are linked to the performance of the Credit Suisse US Balanced 5% ER Index. Credit Suisse International (&#8220;CSI&#8221;), an affiliate of ours, is the &#8220;Index Calculation Agent&#8221; and the &#8220;Index Sponsor.&#8221; For more information on the Underlying, see &#8220;The Underlying&#8221; herein and &#8220;The Credit Suisse US Balanced 5% ER Index&#8221; in the accompanying underlying supplement. The Underlying is identified in the table below, together with its Bloomberg ticker symbol and Initial Level.</FONT></TD></TR>
  <TR>
    <TD ROWSPAN="2" STYLE="padding-left: 5pt; vertical-align: top; width: 18%; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 26%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Underlying</B></P></TD>
    <TD STYLE="vertical-align: bottom; width: 29%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Ticker</B></P></TD>
    <TD STYLE="vertical-align: bottom; width: 27%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Initial Level</B></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Credit Suisse US Balanced 5% ER Index</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>CSEAUSB5 &lt;Index&gt;</B></FONT></TD>
    <TD STYLE="padding-top: 0.5pt; padding-bottom: 0.5pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Upside Participation Rate:</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Expected to be at least 390% (to be determined on the Trade Date).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Redemption&nbsp;Amount:</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">At maturity, for each $1,000 principal amount of securities, you will receive a Redemption Amount in cash that will equal $1,000 multiplied by the sum of one plus the Underlying Return, calculated as set forth below. Any payment on the securities is subject to our ability to pay our obligations as they become due.</FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Underlying&nbsp;Return:</FONT></TD>
    <TD STYLE="padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8226;</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If the Final Level is greater than the Initial Level,&nbsp;an amount calculated as follows:</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-left: 5pt; vertical-align: top; width: 18%; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="width: 20%; padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Upside Participation Rate&nbsp; &times;</FONT></TD>
    <TD STYLE="width: 30%; padding-bottom: 3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><U>Final&nbsp;Level&nbsp;&#8211;&nbsp;Initial&nbsp;Level</U><BR>
Initial&nbsp;Level</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 30%; padding-bottom: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8226;</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If the Final Level is equal to or less than the Initial Level, the Underlying Return will equal zero.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Initial Level:</FONT></TD>
    <TD COLSPAN="4" STYLE="padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The closing level of the Underlying on the Trade Date. In the event that the closing level for the Underlying is not available on the Trade Date, the Initial Level will be determined on the immediately following trading day on which a closing level is available.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Final Level:</FONT></TD>
    <TD COLSPAN="4" STYLE="padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The closing level of the Underlying on the Valuation Date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Valuation Date:</FONT></TD>
    <TD COLSPAN="4" STYLE="padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">September 27, 2027, subject to postponement as set forth in the accompanying product supplement under &#8220;Description of the Securities&#8212;Postponement of calculation dates.&#8221; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Maturity Date:</FONT></TD>
    <TD COLSPAN="4" STYLE="padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">September 30, 2027, subject to postponement as set forth in the accompanying product supplement under &#8220;Description of the Securities&#8212;Postponement of calculation dates.&#8221; If the Maturity Date is not a business day, the Redemption Amount will be payable on the first following business day, unless that business day falls in the next calendar month, in which case payment will be made on the first preceding business day.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Event of Default and Acceleration:</FONT></TD>
    <TD COLSPAN="4" STYLE="padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In case an event of default (as described in the accompanying prospectus) with respect to any issuance of securities shall have occurred and be continuing, the amount declared due and payable upon any acceleration of the securities will be determined by the Calculation Agent and will equal, for each security, the amount to be received on the Maturity Date, calculated as though the date of acceleration were the Valuation Date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5pt; padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">CUSIP:</FONT></TD>
    <TD COLSPAN="4" STYLE="padding-top: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">22553QK55</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0"><B>You may revoke your offer to purchase the securities at any time
prior to the time at which we accept such offer on the date the securities are priced. We reserve the right to change the terms of, or
reject any offer to purchase the securities prior to their issuance. In the event of any changes to the terms of the securities, we will
notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in
which case we may reject your offer to purchase.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 3pt; color: #004E78"><B>Additional Terms Specific to the Securities</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">You should read this pricing supplement together with the underlying
performance supplement dated August 23, 2022, the underlying supplement dated June 18, 2020, the product supplement dated February 4,
2022, the prospectus supplement dated June 18, 2020 and the prospectus dated June 18, 2020, relating to our Medium-Term Notes of which
these securities are a part (together with the pricing supplement, the &#8220;Offering Documents&#8221;). You may access these documents
on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC
website):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8226;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Underlying Performance Supplement dated August 23, 2022:<BR>
</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000121390022050298/s140819_424b3.htm"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">https://www.sec.gov/Archives/edgar/data/1053092/000121390022050298/s140819_424b3.htm</FONT></A></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>Underlying Supplement dated June 18, 2020: <BR>
<A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000089109220007728/e10139-424b2.htm">https://www.sec.gov/Archives/edgar/data/1053092/000089109220007728/e10139-424b2.htm</A></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>Product Supplement No.&nbsp;I&#8211;G dated February 4, 2022: <BR>
<A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000095010322002045/dp166589_424b2-ig.htm">https://www.sec.gov/Archives/edgar/data/1053092/000095010322002045/dp166589_424b2-ig.htm</A></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD>Prospectus Supplement and Prospectus dated June 18, 2020: <BR>
<A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000110465920074474/tm2019510-8_424b2.htm">https://www.sec.gov/Archives/edgar/data/1053092/000110465920074474/tm2019510-8_424b2.htm</A></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">In the event the terms of the securities described in this pricing
supplement differ from, or are inconsistent with, the terms described in the underlying performance supplement, the underlying supplement,
the product supplement, the prospectus supplement or prospectus, the terms described in this pricing supplement will control.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Our Central Index Key, or CIK, on the SEC website is 1053092. As
used in this pricing supplement, &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to Credit Suisse.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">This pricing supplement, together with the documents listed above,
contains the terms of the securities and description of the Underlying and supersedes all other prior or contemporaneous oral statements
as well as any other written materials including preliminary or indicative pricing terms, fact sheets, correspondence, trade ideas, structures
for implementation, sample structures, brochures or other educational materials of ours. We may, without the consent of the registered
holder of the securities and the owner of any beneficial interest in the securities, amend the securities to conform to its terms as set
forth in this pricing supplement and the documents listed above, and the trustee is authorized to enter into any such amendment without
any such consent. You should carefully consider, among other things, the matters set forth in &#8220;Selected Risk Considerations&#8221;
in this pricing supplement, &#8220;Risk Factors&#8221; in the accompanying product supplement, &#8220;Foreign Currency Risks&#8221; in
the accompanying prospectus, and any risk factors we describe in the combined Annual Report on Form 20-F of Credit Suisse Group AG and
us incorporated by reference therein, and any additional risk factors we describe in future filings we make with the SEC under the Securities
Exchange Act of 1934, as amended, as the securities involve risks not associated with conventional debt securities. You should consult
your investment, legal, tax, accounting and other advisors before deciding to invest in the securities.</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; color: #004E78"><B>Hypothetical Redemption Amounts at Maturity</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">The table and examples below illustrate the hypothetical Redemption
Amounts payable at maturity on a $1,000 investment in the securities for a hypothetical range of the performance of the Underlying. The
table and examples below assume that the Upside Participation Rate is 390% (as set forth in &#8220;Key Terms&#8221; herein). The actual
Upside Participation Rate will be determined on the Trade Date. The hypothetical Redemption Amounts set forth below are provided for illustration
purposes only. The actual Redemption Amount applicable to a purchaser of the securities will depend on the Final Level. You should consider
carefully whether the securities are suitable to your investment goals. Any payment on the securities is subject to our ability to pay
our obligations as they become due. The numbers appearing in the table and examples below have been rounded for ease of analysis.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><B>TABLE:</B> Hypothetical Redemption Amounts</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 70%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 34%; padding-right: 0.05in; padding-left: 0.05in">
    <P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0 0 1pt; text-align: center; border-bottom: Black 0.5pt solid"><B>Percentage
    Change from<BR>
    the Initial Level to the<BR>
    Final Level</B></P></TD>
    <TD STYLE="width: 33%; padding-right: 0.05in; padding-left: 0.05in">
    <P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0 0 1pt; text-align: center; border-bottom: Black 0.5pt solid"><B>Underlying
    Return</B></P></TD>
    <TD STYLE="width: 33%; padding-right: 0.05in; padding-left: 0.05in">
    <P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0 0 1pt; text-align: center; border-bottom: Black 0.5pt solid"><B>Redemption
    Amount per<BR>
    $1,000 Principal Amount<BR>
    of Securities</B></P></TD></TR>
  <TR>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">100%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">390%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$4,900 </FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">90%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">351%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$4,510 </FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">80%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">312%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$4,120 </FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">70%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">273%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$3,730 </FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">60%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">234%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$3,340 </FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">50%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">195%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,950 </FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">40%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">156%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,560 </FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">30%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">117%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,170 </FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">20%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">78%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,780 </FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">10%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">39%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,390 </FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>0%</B></FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>0%</B></FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$1,000 </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8722;10%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8722;20%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8722;30%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8722;40%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8722;50%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8722;60%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8722;70%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8722;80%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8722;90%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8722;100%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 12pt"><B>EXAMPLES:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">The following examples illustrate how the Redemption Amount is calculated.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 12pt"><B>Example 1:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">The level of the Underlying increases by 20% from the Initial Level
to the Final Level. The determination of the Redemption Amount when the Final Level is greater than the Initial Level is as follows:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 90%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; padding-right: 0.05in; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Underlying Return</FONT></TD>
    <TD STYLE="width: 3%; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">=</FONT></TD>
    <TD STYLE="width: 77%; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Upside Participation Rate &times; [(Final Level - Initial Level) / Initial Level]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">=</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">390% &times; 20%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">=</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">78%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 0.05in; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Redemption Amount</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">=</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000 &times; (1&nbsp;+&nbsp;Underlying Return)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">=</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000 &times; 1.78</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.05in; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">=</FONT></TD>
    <TD STYLE="padding-right: 0.05in; padding-left: 0.05in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,780</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Because the Final Level is greater than the Initial Level, the Underlying
Return is equal to the appreciation in the Underlying from the Initial Level to the Final Level times the Upside Participation Rate.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><B>Example 2:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">The level of the Underlying decreases by 20% from the Initial Level
to the Final Level. Because the Final Level is equal to or less than the Initial Level, at maturity you would receive a Redemption Amount
equal to $1,000 per $1,000 principal amount of securities.</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; color: #004E78"><B>Selected Risk Considerations</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">An investment in the securities involves significant risks. Investing
in the securities is not equivalent to investing directly in the Underlying. These risks are explained in more detail in the &#8220;Selected
Risk Considerations&#8221; section of the accompanying underlying supplement and the &#8220;Risk Factors&#8221; section of the accompanying
product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><B><I>Risks Relating to the Securities Generally</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>REGARDLESS OF THE AMOUNT OF ANY PAYMENT YOU RECEIVE ON THE SECURITIES, YOUR ACTUAL YIELD MAY BE DIFFERENT IN REAL VALUE TERMS </B>&#8212;
Inflation may cause the real value of any payment you receive on the securities to be less at maturity than it is at the time you invest.
An investment in the securities also represents a forgone opportunity to invest in an alternative asset that generates a higher real return.
You should carefully consider whether an investment that may result in a return that is lower than the return on alternative investments
is appropriate for you.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE SECURITIES DO NOT PAY INTEREST</B>&nbsp;&#8212;&nbsp;We will not pay interest on the securities. You may receive less at maturity
than you could have earned on ordinary interest-bearing debt securities with similar maturities, including other of our debt securities,
since the Redemption Amount is based on the performance of the Underlying. Even if the Redemption Amount is greater than the principal
amount of your securities, the return payable on each security may not be enough to compensate you for any loss in value due to inflation
and other factors relating to the value of money over time.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><B><I>Risks Relating to the Underlying</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.3in; text-indent: -0.3in"><B>THE UNDERLYING DOES NOT ATTEMPT TO
ACHIEVE A BROAD OR &#8220;BALANCED&#8221; ASSET CLASS DIVERSIFICATION</B> &#8212; &#8220;Balanced&#8221; is not meant to imply broad or
balanced diversification across asset classes leading to risk mitigation. The Underlying does not attempt to achieve a broad asset class
diversification, and in some instances may have only equity exposure.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE UNDERLYING HAS LIMITED HISTORY AND MAY PERFORM IN UNEXPECTED WAYS</B> &#8212; The Underlying was launched on June 29, 2018.
Because the Underlying is of recent origin with limited performance history, an investment linked to the Underlying may involve a greater
risk than an investment linked to one or more underlyings with an established record of performance.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>AN INDEX FEE OF 0.50% PER ANNUM IS DEDUCTED IN THE CALCULATION OF THE UNDERLYING</B> &#8212; The index fee will place a drag on
the performance of the Underlying, offsetting any appreciation of its portfolio, exacerbating any depreciation of its portfolio and causing
the level of the Underlying to decline steadily if the value of its portfolio remains relatively constant. The Underlying will not participate
in any appreciation of its portfolio unless it is sufficiently great to offset the negative effects of the index fee, and then only to
the extent that the favorable performance of its portfolio is greater than the index fee (and subject to the volatility-targeting feature).
As a result of this deduction, the level of the Underlying may decline even if its portfolio appreciates.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE UNDERLYING MAY FAIL TO MAINTAIN ITS VOLATILITY TARGET AND MAY EXPERIENCE LARGE DECLINES AS A RESULT</B> &#8212; Because this
exposure adjustment is backward-looking based on realized volatility over a prior period, because past volatility may not be predictive
of future volatility and because there is a time lag between when volatility occurs and when the Underlying rebalances its portfolio,
there may be a time lag before a sudden increase in the volatility of the portfolio of the Component Indices (as defined below) is sufficiently
reflected in the exposure to the portfolio of the Component Indices to result in a meaningful reduction in realized volatility.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE VOLATILITY-TARGETING FEATURE MAY CAUSE THE UNDERLYING TO PERFORM POORLY IN TEMPORARY MARKET CRASHES</B> &#8212; The Underlying
may not meaningfully reduce its exposure to the Underlying&#8217;s hypothetical portfolio until a crash has already occurred, and by the
time the reduced exposure does take effect, the recovery may have already begun.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE VOLATILITY-TARGETING FEATURE COULD CAUSE THE UNDERLYING TO SIGNIFICANTLY UNDERPERFORM ITS PORTFOLIO IN RISING EQUITY MARKETS</B>
&#8212; The Underlying will have less than 100% exposure to the Underlying&#8217;s hypothetical portfolio at any time when realized volatility
of the Underlying&#8217;s hypothetical portfolio is greater than the Underlying&#8217;s volatility target of 5%.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE UNDERLYING&#8217;S VOLATILITY TARGET IS ARBITRARY</B> &#8212; The Underlying&#8217;s target realized volatility of 5% is one
of many volatility targets that CSI could have selected and may not be the optimal target volatility for the Underlying.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE UNDERLYING&#8217;S DECAY FACTORS ARE ARBITRARY</B> &#8212; The decay factors were chosen arbitrarily by CSI out of many decay
factors that CSI could have selected, and may not be the optimal decay factors to use for the Underlying.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>CALCULATING THE PRELIMINARY WEIGHT OF THE EQUITY INDEX IN THE UNDERLYING&#8217;S PORTFOLIO BASED ON THE ARITHMETIC AVERAGE OF THE
SHORT-TERM AND LONG-TERM REALIZED VOLATILITIES OF THE EQUITY INDEX IS ARBITRARY</B> &#8212; This averaging of short-term realized volatility
and long-term realized volatility is arbitrary and may dampen or heighten the calculated realized volatility of the Equity Index compared
to other methods of calculating volatility such as implied volatility, which is an estimation of future volatility and may better reflect
market volatility expectation.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>A SIGNIFICANT PORTION OF THE UNDERLYING MAY BE HYPOTHETICALLY ALLOCATED TO NON-REMUNERATING CASH, WHICH MAY DAMPEN RETURNS</B>
&#8212; At any time when the Underlying has less than 100% exposure to the Underlying&#8217;s hypothetical portfolio, a portion of the
Underlying (corresponding to the difference between the exposure to the Underlying&#8217;s hypothetical portfolio and 100%) will be hypothetically
allocated to non-remunerating cash and will not accrue any interest or other return.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE UNDERLYING IS EXPOSED TO RISKS RELATED TO THE COMPONENT INDICES</B> &#8212; The Underlying&#8217;s performance will be directly
affected by the performance of the Component Indices and the risks related to the Component Indices.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE UNDERLYING&#8217;S ALLOCATION METHODOLOGY MAY NOT BE SUCCESSFUL IF THE EQUITY INDEX AND THE FIXED INCOME INDICES DECLINE AT
THE SAME TIME</B> &#8212; If the Equity Index and the Fixed Income Indices tend to decline at the same time&#8212;in other words, if they
prove to be positively correlated&#8212;the Underlying&#8217;s allocation methodology will not be successful, and the Underlying may experience
significant declines.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><B>THE UNDERLYING MAY HAVE SIGNIFICANT EXPOSURE TO THE FIXED INCOME INDICES, WHICH HAVE LIMITED RETURN POTENTIAL AND SIGNIFICANT DOWNSIDE
POTENTIAL, PARTICULARLY IN TIMES OF RISING INTEREST RATES</B> &#8212; The Fixed Income Indices offer only limited return potential, which
in turn limits the return potential of the Underlying.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE PROBABILITY THAT THE UNDERLYING RETURN WILL BE ZERO WILL DEPEND ON THE VOLATILITY OF THE UNDERLYING</B> &#8212; &#8220;Volatility&#8221;
refers to the frequency and magnitude of changes in the level of the Underlying. The greater the expected volatility with respect to the
Underlying on the Trade Date, the higher the expectation as of the Trade Date that the Final Level could be less than the Initial Level,
and that you would receive only the principal amount of $1,000 for each $1,000 principal amount of securities. The terms of the securities
are set, in part, based on expectations about the volatility of the Underlying as of the Trade Date. The volatility of the Underlying
can change significantly over the term of the securities. The level of the Underlying could fall sharply and you could receive only the
principal amount of $1,000 for each $1,000 principal amount of securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">For information regarding the risks associated with the hypothetical
back-tested performance information, see &#8220;The Underlying &#8212; Back-Tested and Actual Historical Information&#8221; in this pricing
supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><B>Risks Relating to the Component Indices</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">Because the Underlying&#8217;s portfolio will consist of the Equity
Index and, in certain circumstances, also of the Fixed Income Indices (the Equity Index and the Fixed Income Indices are herein collectively
referred to as the &#8220;Component Indices&#8221;), the securities are subject to the following risks related to the Component Indices:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><FONT STYLE="text-transform: uppercase"><B>THE Securities Do Not Offer Direct Exposure to the S&amp;P 500<SUP>&reg;</SUP> Index or
U.S. Treasury Notes </B></FONT>&#8212; The Equity Index tracks E-mini S&amp;P 500 futures contracts, not the underlying S&amp;P 500<SUP>&reg;</SUP>
Index (nor the immediate value of its components), the Fixed Income Indices track the relevant U.S. Treasury note futures contracts, not
the underlying U.S. Treasury notes (nor their spot price), and the securities may underperform a similar investment linked to the spot
prices or current levels of the assets underlying the futures contracts tracked by the Component Indices.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><FONT STYLE="text-transform: uppercase"><B>The Level of the Component Indices May be Calculated and Published at Different Times than
the Prices of the E-mini S&amp;P 500 Futures Contracts or U.S. Treasury Note Futures Contracts</B></FONT> &#8212; There could be market
developments or other events that cause or exacerbate the difference between the price of the E-mini S&amp;P 500 futures contracts or
U.S. Treasury note futures contracts and the level of the Equity Index or the Futures Indices, as relevant.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><FONT STYLE="text-transform: uppercase"><B>Higher Future Prices of Futures Contracts Relative to Their Current Prices, or &#8220;Contango&#8221;,
May Lead to a Decrease in the Level of the Component Indices and the Amount Payable on the Securities </B></FONT>&#8212; If the market
for futures contracts tracked by the Component Indices is in &#8220;contango&#8221; (where the prices are higher in the distant delivery
months than in the nearer delivery months) or, to the contrary, in &#8220;backwardation&#8221;, this could create a negative or positive
&#8220;carry&#8221; or &#8220;roll yield&#8221; when such contracts are &#8220;rolled&#8221; and could adversely affect the levels of
the Component Indices, and, therefore, the amount payable at maturity or upon repurchase and/or the market value of the securities.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><FONT STYLE="text-transform: uppercase"><B>The Securities Are Subject to Interest Rate Risk </B></FONT>&#8212; Fluctuations in interest
rates could affect the level of the U.S. Treasury Note futures contracts, the levels of the Fixed Income Indices, and, therefore, the
amount payable at maturity or upon repurchase and/or the market value of the securities.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><FONT STYLE="text-transform: uppercase"><B>The Securities Are Subject to Equity Market Risk </B></FONT>&#8212; Fluctuations in equity
market prices could affect the level of the E-mini S&amp;P 500 futures contracts, the level of the Equity Index, and, therefore, the amount
payable at maturity or upon repurchase and/or the market value of the securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><B>Risks Relating to the Underlying and the Component Indices</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">The following risks relate generally to the Underlying and the Component
Indices, which are referred to collectively below as the &#8220;indices&#8221; and the respective components of the Component Indices
as the &#8220;index components&#8221;.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><B>PAST PERFORMANCE OF THE INDICES IS NO GUIDE TO FUTURE PERFORMANCE AND THERE IS NO ASSURANCE THAT THE STRATEGIES ON WHICH THE INDICES
ARE BASED WILL BE SUCCESSFUL</B> &#8212; We cannot predict the future performance of the indices and there is no assurance that the strategy
on which the indices is based will be successful in producing positive returns.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><B>THERE CAN BE NO ASSURANCE THAT THE PERFORMANCE OF THE INDICES OVER TIME WILL APPROXIMATE THE RETURN OF THE RELEVANT STRATEGY OR
ANY OTHER STRATEGY</B> &#8212; The composition of the indices at any time is determined by the allocation methodology, and is not actively
managed by the relevant index sponsor. There can be no assurance that the performance of the indices over time will approximate the return
of the relevant strategy or any other strategy.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><B>YOU WILL NOT HAVE ANY RIGHTS IN ANY U.S. EQUITY FUTURES CONTRACTS OR U.S. TREASURY NOTE FUTURES CONTRACTS TRACKED BY THE INDICES</B>
&#8212; The securities will be paid in cash, and you will have no right to receive any payment or delivery in respect of any E-mini S&amp;P
500 futures contracts or U.S. Treasury note futures contracts.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><B>OWNING THE SECURITIES IS NOT THE SAME AS DIRECTLY OWNING ANY FUTURES CONTRACTS OR SECURITIES DIRECTLY OR INDIRECTLY TRACKED BY
THE INDICES</B> &#8212; For example, as an investor in the securities, you will not have rights to receive dividends or other distributions
or any other rights, including voting rights, with respect to any stocks included in the S&amp;P 500<SUP>&reg;</SUP> Index tracked by
the E-mini S&amp;P 500 futures, which are, in turn, tracked by the Equity Index.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><B>SUSPENSION OR DISRUPTIONS OF MARKET TRADING IN STOCKS OR FUTURES CONTRACTS MAY ADVERSELY AFFECT THE VALUE OF THE SECURITIES</B>
&#8212; Stock markets and futures markets are subject to temporary distortions or other disruptions due to various factors, including
the lack of liquidity in the markets, the participation of speculators, and government regulation and intervention. These circumstances
could affect the level of the indices and the market value of the securities.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD STYLE="text-align: left"><FONT STYLE="text-transform: uppercase"><B>We and Our Affiliates May Have Economic Interests Adverse to Those of the Holders of the
Securities</B></FONT> &#8212; Potential conflicts of interest may exist between our affiliates and you, including with respect to certain
determinations and judgments that they must make in determining amounts due to you, either at maturity or upon early redemption of the
securities or the composition or methodology of the indices.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>ADJUSTMENTS TO THE INDICES AND/OR TO THE RESPECTIVE INDEX COMPONENTS COULD ADVERSELY AFFECT THE PERFORMANCE OF THE INDICES</B>
&#8212; The relevant index sponsor can make methodological changes to the relevant index that could change the level of such index at
any time. Any action by the relevant index sponsor could adversely affect the amount payable at maturity or repurchase and/or the market
value of the securities.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>YOU WILL HAVE NO RIGHTS AGAINST THE ENTITIES WITH DISCRETION OVER THE INDICES OR THE RESPECTIVE INDEX COMPONENTS</B> &#8212; As
an owner of the securities, you will have no rights against the relevant index sponsor or the index calculation agent even though the
amount you receive at maturity or upon repurchase of your securities by Credit Suisse will depend on the level of the indices.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE INDICES WILL BE CALCULATED PURSUANT TO A SET OF FIXED RULES AND WILL NOT BE ACTIVELY MANAGED. IF THE INDICES PERFORM POORLY,
THE RELEVANT INDEX SPONSOR WILL NOT CHANGE THE RULES IN AN ATTEMPT TO IMPROVE PERFORMANCE</B> &#8212; Unlike a mutual fund, which could
be actively managed by the fund manager in an attempt to maximize returns in changing market conditions, the index rules will remain unchanged,
even if those rules might prove to be ill-suited to future market conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">For more information on the Underlying and the risks associated with
an investment in securities linked to the Underlying, see &#8220;The Underlying&#8221; herein, and &#8220;Selected Risk Considerations&#8221;,
&#8220;The Credit Suisse US Balanced 5% ER Index&#8221; and &#8220;The Futures Indices&#8221; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><B><I>Risks Relating to the Issuer</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE SECURITIES ARE SUBJECT TO THE CREDIT RISK OF CREDIT SUISSE </B>&#8212; Investors are dependent on our ability to pay all amounts
due on the securities and, therefore, if we were to default on our obligations, you may not receive any amounts owed to you under the
securities. In addition, any decline in our credit ratings, any adverse changes in the market's view of our creditworthiness or any increase
in our credit spreads is likely to adversely affect the value of the securities prior to maturity.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>CREDIT SUISSE IS SUBJECT TO SWISS REGULATION </B>&#8212; As a Swiss bank, Credit Suisse is subject to regulation by governmental
agencies, supervisory authorities and self-regulatory organizations in Switzerland. Such regulation is increasingly more extensive and
complex and subjects Credit Suisse to risks. For example, pursuant to Swiss banking laws, the Swiss Financial Market Supervisory Authority
(FINMA) may open resolution proceedings if there are justified concerns that Credit Suisse is over-indebted, has serious liquidity problems
or no longer fulfills capital adequacy requirements. FINMA has broad powers and discretion in the case of resolution proceedings, which
include the power to convert debt instruments and other liabilities of Credit Suisse into equity and/or cancel such liabilities in whole
or in part. If one or more of these measures were imposed, such measures may adversely affect the terms and market value of the securities
and/or the ability of Credit Suisse to make payments thereunder and you may not receive any amounts owed to you under the securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><B><I>Risks Relating to Conflicts of Interest</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>HEDGING AND TRADING ACTIVITY</B> &#8212; We or any of our affiliates may carry out hedging activities related to the securities,
including in instruments related to the Underlying and the Component Indices. We or our affiliates may also trade instruments related
to the Underlying and/or the Component Indices from time to time. Any of these hedging or trading activities on or prior to the Trade
Date and during the term of the securities could adversely affect our payment to you at maturity.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>POTENTIAL CONFLICTS </B>&#8212; We and our affiliates play a variety of roles in connection with the issuance of the securities,
including acting as calculation agent and as agent of the issuer for the offering of the securities, hedging our obligations under the
securities and determining their estimated value. In addition, an affiliate of ours, Credit Suisse International, is the Index Calculation
Agent and the Index Sponsor for the Underlying and the index calculation agent for the Equity Index and the Fixed Income Indices, and
another affiliate of ours, Credit Suisse Securities (Europe) Limited (&#8220;CSSEL&#8221;), is the sponsor of the Equity Index and the
Fixes Income Indices. In performing these duties, the economic interests of us and our affiliates are potentially adverse to your interests
as an investor in the securities. Further, hedging activities may adversely affect any payment on or the value of the securities. Any
profit in connection with such hedging activities will be in addition to any other compensation that we and our affiliates receive for
the sale of the securities, which creates an additional incentive to sell the securities to you.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.25in">Because our affiliates are initially acting as the index calculation
agent and as the sponsor of the Underlying, the Equity Index and the Fixed Income Indices, potential conflicts of interest may exist between
our affiliates and you, including, without limitation, with respect to certain determinations and judgments that they must make in determining
amounts due to you at maturity or the composition or methodology of the Underlying, the Equity Index and the Fixed Income Indices.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"><B><I>Risks Relating to the Estimated Value and Secondary Market
Prices of the Securities</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>UNPREDICTABLE ECONOMIC AND MARKET FACTORS WILL AFFECT THE VALUE OF THE SECURITIES</B>&nbsp;&#8212;The payout on the securities
can be replicated using a combination of the components described in &#8220;The estimated value of the securities on the Trade Date may
be less than the Price to Public.&#8221; Therefore, in addition to the level of the Underlying, the terms of the securities at issuance
and the value of the securities prior to and at maturity may be influenced by factors that impact the value of equity securities, fixed
income securities and options in general, such as:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21.75pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the expected and actual volatility of the Underlying;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21.75pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the time to maturity of the securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21.75pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">market prices of the U.S. Treasury notes on which the futures contracts tracked
by the Component Indices are based;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21.75pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the dividend rate on the equity securities indirectly tracked by the Equity
Index;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21.75pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">interest and yield rates in the market generally;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21.75pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">investors&#8217; expectations with respect to the rate of inflation;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21.75pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">geopolitical conditions and economic, financial, political, regulatory or
judicial events that affect the equity securities or U.S. Treasury note futures contracts tracked, directly or indirectly, by the Component
Indices or markets generally and which may affect the level of the Underlying; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21.75pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">our creditworthiness, including actual or anticipated downgrades in our credit
ratings.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0pt 12pt 0.25in">Some or all of these factors may influence the price that
you will receive if you choose to sell your securities prior to maturity. The impact of any of the factors set forth above may enhance
or offset some or all of any change resulting from another factor or factors.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>THE ESTIMATED VALUE OF THE SECURITIES ON THE TRADE DATE MAY BE LESS THAN THE PRICE TO PUBLIC </B>&#8212; The initial estimated
value of your securities on the Trade Date (as determined by reference to our pricing models and our internal funding rate) may be significantly
less than the original Price to Public. The Price to Public of the securities includes any discounts or commissions as well as transaction
costs such as expenses incurred to create, document and market the securities and the cost of hedging our risks as issuer of the securities
through one or more of our affiliates (which includes a projected profit). These costs will be effectively borne by you as an investor
in the securities. These amounts will be retained by Credit Suisse or our affiliates in connection with our structuring and offering of
the securities (except to the extent discounts or commissions are reallowed to other broker-dealers or any costs are paid to third parties).</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.25in">On the Trade Date, we value the components of the securities
in accordance with our pricing models. These include a fixed income component valued using our internal funding rate, and individual option
components valued using proprietary pricing models dependent on inputs such as volatility, correlation, dividend rates, interest rates
and other factors, including assumptions about future market events and/or environments. These inputs may be market-observable or may
be based on assumptions made by us in our discretionary judgment. As such, the payout on the securities can be replicated using a combination
of these components and the value of these components, as determined by us using our pricing models, will impact the terms of the securities
at issuance. Our option valuation models are proprietary. Our pricing models take into account factors such as interest rates, volatility
and time to maturity of the securities, and they rely in part on certain assumptions about future events, which may prove to be incorrect.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.25in">Because Credit Suisse&#8217;s pricing models may differ from
other issuers' valuation models, and because funding rates taken into account by other issuers may vary materially from the rates used
by Credit Suisse (even among issuers with similar creditworthiness), our estimated value at any time may not be comparable to estimated
values of similar securities of other issuers.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>EFFECT OF INTEREST RATE USED IN STRUCTURING THE SECURITIES </B>&#8212; The internal funding rate we use in structuring notes such
as these securities is typically lower than the interest rate that is reflected in the yield on our</TD></TR></TABLE>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.25in">conventional debt securities of similar
maturity in the secondary market (our &#8220;secondary market credit spreads&#8221;). If on the Trade Date our internal funding rate is
lower than our secondary market credit spreads, we expect that the economic terms of the securities will generally be less favorable to
you than they would have been if our secondary market credit spread had been used in structuring the securities. We will also use our
internal funding rate to determine the price of the securities if we post a bid to repurchase your securities in secondary market transactions.
See &#8220;&#8212;Secondary Market Prices&#8221; below.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>SECONDARY MARKET PRICES </B>&#8212; If Credit Suisse (or an affiliate) bids for your securities in secondary market transactions,
which we are not obligated to do, the secondary market price (and the value used for account statements or otherwise) may be higher or
lower than the Price to Public and the estimated value of the securities on the Trade Date. The estimated value of the securities on the
cover of this pricing supplement does not represent a minimum price at which we would be willing to buy the securities in the secondary
market (if any exists) at any time. The secondary market price of your securities at any time cannot be predicted and will reflect the
then-current estimated value determined by reference to our pricing models, the related inputs and other factors, including our internal
funding rate, customary bid and ask spreads and other transaction costs, changes in market conditions and deterioration or improvement
in our creditworthiness. In circumstances where our internal funding rate is higher than our secondary market credit spreads, our secondary
market bid for your securities could be less favorable than what other dealers might bid because, assuming all else equal, we use the
higher internal funding rate to price the securities and other dealers might use the lower secondary market credit spread to price them.
Furthermore, assuming no change in market conditions from the Trade Date, the secondary market price of your securities will be lower
than the Price to Public because it will not include any discounts or commissions and hedging and other transaction costs. If you sell
your securities to a dealer in a secondary market transaction, the dealer may impose an additional discount or commission, and as a result
the price you receive on your securities may be lower than the price at which we may repurchase the securities from such dealer.</TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.25in">We (or an affiliate) may initially post a bid to repurchase
the securities from you at a price that will exceed the then-current estimated value of the securities. That higher price reflects our
projected profit and costs, which may include discounts and commissions that were included in the Price to Public, and that higher price
may also be initially used for account statements or otherwise. We (or our affiliate) may offer to pay this higher price, for your benefit,
but the amount of any excess over the then-current estimated value will be temporary and is expected to decline over a period of approximately
three months.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.25in">The securities are not designed to be short-term trading instruments
and any sale prior to maturity could result in a substantial loss to you. You should be willing and able to hold your securities to maturity.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&#8226;</TD><TD><B>LACK OF LIQUIDITY </B>&#8212; The securities will not be listed on any securities exchange. Credit Suisse (or its affiliates) intends
to offer to purchase the securities in the secondary market but is not required to do so. Even if there is a secondary market, it may
not provide enough liquidity to allow you to trade or sell the securities when you wish to do so. Because other dealers are not likely
to make a secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the
price, if any, at which Credit Suisse (or its affiliates) is willing to buy the securities. If you have to sell your securities prior
to maturity, you may not be able to do so or you may have to sell them at a substantial loss.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; color: #004E78"><B>Supplemental Use of Proceeds and Hedging</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">We intend to use the proceeds of this offering for our general corporate
purposes, which may include the refinancing of existing debt outside Switzerland. Some or all of the proceeds we receive from the sale
of the securities may be used in connection with hedging our obligations under the securities through one or more of our affiliates. Such
hedging or trading activities on or prior to the Trade Date and during the term of the securities (including on any calculation date,
as defined in any accompanying product supplement) could adversely affect the value of the Underlying and, as a result, could decrease
the amount you may receive on the securities at maturity. For additional information, see &#8220;Supplemental Use of Proceeds and Hedging&#8221;
in any accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; color: #004E78"><B>The Underlying</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-indent: 0in">We have derived all disclosure contained in this
Pricing Supplement and the Underlying Supplement regarding the Underlying, including, without limitation, its make-up, method of calculation
and changes to its components, from information prepared by CSI and from publicly available information. We have derived all disclosure
contained in this Pricing Supplement and the Underlying Supplement regarding the Equity Index and the Fixed Income Indices, including,
without limitation, their respective make-up, method of calculation and changes to their components, from information prepared by CSSEL.
Neither we nor any of our affiliates assumes any responsibility for the accuracy or adequacy of any information contained in any public
disclosure of information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-indent: 0in"><B>Overview</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-indent: 0in">The Underlying is designed to provide exposure to
a hypothetical &#8220;balanced&#8221; portfolio (consisting of the Equity Index and a momentum strategy-driven allocation of the Fixed
Income Indices), while targeting a realized daily volatility of 5%. By &#8220;balanced&#8221; we mean the Underlying&#8217;s hypothetical
portfolio may, under certain circumstances, include both:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 38.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">equity exposure, in the form of notional E-mini S&amp;P 500 futures contracts
tracked by the Credit Suisse US Equity Futures Index (the &#8220;Equity Index&#8221;); and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 38.15pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">fixed income exposure, in the form of notional U.S. Treasury note futures
contracts tracked by the Credit Suisse 10-Year U.S. Treasury Note Futures Index, alone or together with the Credit Suisse 2-Year U.S.
Treasury Note Futures Index (together, the &#8220;Fixed Income Indices&#8221;). </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-indent: 0in">The Credit Suisse US Balanced Index is meant to
represent an unfunded (excess return) exposure allocated to the Equity Index and the Futures Indices. <B>&#8220;Balanced&#8221; does not
imply any risk adjusted diversified asset class allocation or actual balance among asset classes.</B> See &#8220;Selected Risk Considerations&#8212;There
Are Risks Related to the Underlying&#8221; herein and &#8220;Selected Risk Considerations&#8212;Selected Risk Factors Related to the Credit
Suisse US Balanced Index&#8212;The Credit Suisse US Balanced Index Does Not Attempt to Achieve a Broad or &#8220;Balanced&#8221; Asset
Class Diversification&#8221; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-indent: 0in">The components of the Equity Index provide notional
exposure to E-mini S&amp;P 500 futures, which are futures contracts on the S&amp;P 500<SUP>&reg;</SUP> Index that are traded on Chicago
Mercantile Exchange. Each E-mini S&amp;P 500 futures contract has a notional value of $50 multiplied by the value of the S&amp;P 500<SUP>&reg;</SUP>
Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-indent: 0in">Depending on market conditions, the Underlying may
allocate exposure to one or both Fixed Income Indices that track the performance of notional long investments in two- and ten-year U.S.
Treasury note futures contracts. U.S. Treasury notes are U.S. government debt securities issued by the U.S. Treasury.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-indent: 0in">The Equity Index and the Fixed Income Indices are
described in greater detail in &#8220;The Futures Indices&#8221; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">The Index Calculation Agent deducts an index fee in the calculation
of the Underlying. The index fee is deducted from the daily performance of the Underlying at a rate of 0.50% per annum. The annualized
index fee reduces the level of the Underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">For additional information on the Underlying, see &#8220;The Credit
Suisse US Balanced 5% ER Index&#8221; in the accompanying underlying supplement.</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt"><B>Back-Tested and Actual Historical Information</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">The following graph sets forth the performance of the Underlying based
on the back-tested closing levels of the Underlying from January 1, 2008 through June 29, 2018 and on the actual historical closing levels
from June 29, 2018 through August 29, 2022. The vertical line on the graph indicates the inception date of the Underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">You should not take the historical levels of the Underlying as an
indication of future performance of the Underlying or the securities. Any historical trend in the level of the Underlying during any period
set forth below is not an indication that the level of the Underlying is more or less likely to increase or decrease at any time over
the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt"><I>Limitations of Back-Tested Performance Information</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">The Underlying was launched on June 29, 2018, and, therefore, performance
information in the following graph prior to such date has been back-tested. It is important to understand that back-tested performance
information is subject to significant limitations, in addition to the fact that past performance is never a guarantee of future performance.
In particular:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The Index Sponsor developed the rules of the Underlying with the benefit of
hindsight&#8212;that is, with the benefit of being able to evaluate how the Underlying&#8217;s rules would have caused the Underlying
to perform had it existed during the back-tested period. The fact that the Underlying generally appreciated over a given back-tested period
may not therefore be an accurate or reliable indication of any fundamental aspect of the Underlying&#8217;s methodology. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The back-tested performance of the Underlying might look different if it covered
a different historical period. The market conditions that existed during the historical period covered by the back-tested performance
information are not necessarily representative of the market conditions that will exist in the future. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Because the Component Indices were not published during the entire period
for which the Index Sponsor has prepared the back-tested performance information, the back-tested closing levels of the Underlying have
been calculated by the Index Sponsor based in part on back-tested levels of the Component Indices that were prepared by their respective
sponsors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">It is impossible to predict whether the Underlying will rise or fall.
The actual future performance of the Underlying may bear no relation to the actual historical or back-tested levels of the Underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">For additional information on the Underlying, see &#8220;The Credit
Suisse US Balanced 5% ER Index&#8221; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">The closing level of the Underlying on August 29, 2022 was 234.1086.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 268px; width: 446px"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; text-indent: 0in; color: #005288"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in; color: #005288"><B>United States Federal Tax Considerations
</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">This discussion supplements and, to the extent inconsistent therewith, supersedes
the discussion in the accompanying product supplement under &#8220;Material United States Federal Income Tax Considerations.&#8221; The
discussions below and in the accompanying product supplement do not address the consequences to taxpayers subject to special tax accounting
rules under Section 451(b) of the Internal Revenue Code.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">In the opinion of our counsel, Latham &amp; Watkins LLP, the securities
should be treated as &#8220;contingent payment debt instruments&#8221; for U.S. federal income tax purposes, as described in the section
of the accompanying product supplement called &#8220;Material United States Federal Income Tax Considerations&#8212;U.S. Holders&#8212;Contingent
Payment Debt Instruments,&#8221; and the remaining discussion assumes that this treatment of the securities is respected.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">If you are a U.S. Holder, you will be required to recognize interest income
during the term of the securities at the &#8220;comparable yield,&#8221; which generally is the yield at which we could issue a fixed-rate
debt instrument with terms similar to those of the securities, including the level of subordination, term, timing of payments and general
market conditions, but excluding any adjustments for the riskiness of the contingencies or the liquidity of the securities. We are required
to construct a &#8220;projected payment schedule&#8221; in respect of the securities representing a payment the amount and timing of which
would produce a yield to maturity on the securities equal to the comparable yield. Assuming you hold the securities until their maturity,
the amount of interest you include in income based on the comparable yield in the taxable year in which the securities mature will be
adjusted upward or downward to reflect the difference, if any, between the actual and projected payment on the securities at maturity
as determined under the projected payment schedule.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Upon the sale, exchange or retirement of the securities prior to maturity,
you generally will recognize gain or loss equal to the difference between the proceeds received and your adjusted tax basis in the securities.
Your adjusted tax basis will equal your purchase price for the securities, increased by interest previously included in income on the
securities. Any gain generally will be treated as ordinary income, and any loss generally will be treated as ordinary loss to the extent
of prior interest inclusions on the security and as capital loss thereafter.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">We will determine the comparable yield for the securities and will provide
that comparable yield, and the projected payment schedule, in the final pricing supplement for the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>Neither the comparable yield nor the projected payment schedule constitutes
a representation by us regarding the actual amount that we will pay on the securities.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">A change in the methodology by which the Underlying is calculated, a change
in the components of the Underlying (including the weighting of such components) or other similar circumstances resulting in a material
change to the Underlying could result in a significant modification of the securities. We believe that a rebalancing of the Underlying
generally should not be treated as a significant modification. If, however, a significant modification of the securities did occur, it
would generally result in the securities being treated as terminated and reissued for U.S. federal income tax purposes. As a result, you
might be required to recognize gain or loss (subject to the possible application of the wash sale rules) with respect to the securities,
and the tax consequences of owning the securities thereafter could be affected. You should consult your tax advisor regarding the treatment
of the securities in such an event.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt"><B>Non-U.S. Holders. </B>Subject to the discussions in the next paragraph
and in &#8220;Material United States Federal Income Tax Considerations&#8221; in the accompanying product supplement, if you are a Non-U.S.
Holder (as defined in the accompanying product supplement) of the securities, you generally will not be subject to U.S. federal withholding
or income tax in respect of any amount paid to you with respect to the securities, provided that (i) income in respect of the securities
is not effectively connected with your conduct of a trade or business in the United States, and (ii) you comply with the applicable certification
requirements. See &#8220;Material United States Federal Income Tax Considerations &#8212;Non-U.S. Holders Generally&#8221; in the accompanying
product supplement for a more detailed discussion of the rules applicable to Non-U.S. Holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">As discussed under &#8220;Material United States Federal Income Tax Considerations&#8212;Non-U.S.
Holders Generally&#8212;Substitute Dividend and Dividend Equivalent Payments&#8221; in the accompanying product supplement, Section 871(m)
of the Internal Revenue Code generally imposes a 30% withholding tax on &#8220;dividend equivalents&#8221; paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities or indices that include U.S. equities. Treasury regulations
under Section 871(m), as modified by an Internal Revenue Service (the &#8220;IRS&#8221;) notice, exclude from their scope financial instruments
issued prior to January 1, 2023 that do not have a &#8220;delta&#8221; of one with respect to any U.S. equity. Based on the terms of the
securities and representations provided by us as of the date of this preliminary pricing supplement, our counsel is of the opinion that
the securities should not be treated as transactions that have a &#8220;delta&#8221; of</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">one within the meaning of the regulations with respect to any U.S. equity
and, therefore, should not be subject to withholding tax under Section 871(m). However, the final determination regarding the treatment
of the securities under Section 871(m) will be made as of the Trade Date for the securities and it is possible that the securities will
be subject to withholding tax under Section 871(m) based on circumstances on that date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">A determination that the securities are not subject to Section 871(m) is
not binding on the IRS, and the IRS may disagree with this determination. Moreover, Section 871(m) is complex and its application may
depend on your particular circumstances, including whether you enter into other transactions with respect to a U.S. equity to which the
securities relate. You should consult your tax advisor regarding the potential application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="background-color: white">We will not be required to pay any
additional amounts with respect to U.S. federal withholding taxes.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>FATCA. </B>You should review the section entitled &quot;Material United
States Federal Income Tax Considerations&#8212;Securities Held Through Foreign Entities&quot; in the accompanying product supplement regarding
withholding rules under the &#8220;FATCA&#8221; regime. The discussion in that section is modified to reflect regulations proposed by
the U.S. Treasury Department indicating an intent to eliminate the requirement under FATCA of withholding on gross proceeds of the disposition
of affected financial instruments. The U.S. Treasury Department has indicated that taxpayers may rely on these proposed regulations pending
their finalization.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt"><B>You should read the section entitled &#8220;Material United States
Federal Income Tax Considerations&#8221; in the accompanying product supplement. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt"><B>You should also consult your tax advisor regarding all aspects
of the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; color: #004E78"><B>Supplemental Plan of Distribution (Conflicts of
Interest)</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">Under the terms and subject to the conditions contained in a distribution
agreement dated May 7, 2007, as amended, which we refer to as the distribution agreement, we have agreed to sell the securities to CSSU.
We may also agree to sell the securities to other agents that are parties to the distribution agreement. We refer to CSSU and other such
agents as the &#8220;Agents.&#8221;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">The distribution agreement provides that the Agents are obligated
to purchase all of the securities if any are purchased.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">The Agents may offer the securities at the offering price set forth
on the cover page of this pricing supplement and may receive varying discounts and commissions of up to $37.50 per $1,000 principal amount
of securities. The Agents may re-allow some or all of the discount on the principal amount per security on sales of such securities by
other brokers or dealers. CSSU or another broker or dealer will forgo some or all discounts and commissions with respect to the sales
of securities into certain fiduciary accounts. If all of the securities are not sold at the initial offering price, the Agents may change
the public offering price and other selling terms.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">An affiliate of Credit Suisse has paid or may pay in the future a
fixed amount to broker-dealers in connection with the costs of implementing systems to support these securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">We expect to deliver the securities against payment for the securities
on the Settlement Date indicated herein, which may be a date that is greater than two business days following the Trade Date. Under Rule
15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in two business
days, unless the parties to a trade expressly agree otherwise. Accordingly, if the Settlement Date is more than two business days after
the Trade Date, purchasers who wish to transact in the securities more than two business days prior to the Settlement Date will be required
to specify alternative settlement arrangements to prevent a failed settlement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">CSSU is our affiliate. In accordance with FINRA Rule 5121, CSSU may
not make sales in this offering to any of its discretionary accounts without the prior written approval of the customer. A portion of
the net proceeds from the sale of the securities will be used by CSSU or one of its affiliates in connection with hedging our obligations
under the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">For further information, please refer to &#8220;Underwriting (Conflicts
of Interest)&#8221; in any accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>Credit Suisse</B></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  _ /T# 2(  A$! Q$!_\0
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M9)IN*_FCSI]&KV:]5V_4T<K1E*S]R3C):76CE??X;)N[^XL456$CX)))^9@
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MN-?M[9?)L/@OXNU2[F#2ZW:6R);?#35;J:1]=MH!X/GN9-9A\-VNK_E;I/\
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M9\0VFL?$B32-/^'47A>\L/"<^ISV<=S!9VOC+4=,TBYUHZ;!J%Y8Z4;N6/\
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MMK6PA^@I?F(.5ZD?,-WITZXZCC\B>TPB0# !'T9@>I/4'/4D]>22>M/P/?\
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L2O=ZGT,(N,8KF<FH*,FVDY-))SDH*%-RE:[M3BKMVMHA:***"PHHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %H E<# 2(  A$! Q$!_\0
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MZ5P01,?3I13[S_DH>C?]@J__ /1MI10 >'O^0YXL_P"PK'_Z16M=!7/^'O\
MD.>+/^PK'_Z16M=!0 4444 %%%% !1110 4444 97_"06G_"-'7?+F^RB$S;
M-HWX'MG&?QJR^IVL+W0N)HX([;9YDDLJ!1NZ9YRO_ @,]LUQA\.L?ANX\K4O
MMWV1O]'^TS_>]/*W8_#%7]0LBVKZI<3P:BL0N+22*:SB#LK*I&X*0=P!." &
M//3T -NZ\2:5:+8.UY"\=]*8H9$E4J< Y;.>@(P2,\D#O5L:E8F_-@+VV-X!
MDV_FKY@XS]W.>G-<I$M^UGID]S:.PAU?>TT-DT3S)Y3*9GB&64ECSP.QP!38
M[2Y^Q6FD_8K@:C#JHN9+@PMY>WS"YE\S&ULH=N,[N<$<&@#IWUS3A*L,5Y;S
M2F18VCCGCW*2VWD%AWXQU[ $U,-2L3?FP%[;&\ R;?S5\P<9^[G/3FN4@T^Y
M31;=!:3+(=>\]U\LYV>>3O/MMP<^E6M+ L[-=-NM(N+F_CNI9=WV<^6S%F82
M^:?EY4@==W.,=10!OV^KZ;=736MOJ%I-<+G=%',K.,=<@'/%1VVL6]UH*ZPB
M2BW: SA6 W[0,XQG&?QKD]-2^GUSP_-+!=*L'F"2%-.-O;VA:$C8N1N/(.6W
M%>G3(%:^E6MQ'\.8K5X)5N!I[(8F0A]VT\8ZY]J +</B)7%I)/IM]:V]VR)%
M/+Y14E_N@['8C/ Y'4BM :E8F_-@+VV-X!DV_FKY@XS]W.>G-9&F:"\FGZ6;
M^_OIEMTBE6UE$:*CJHQG:@8[3V)Z@9S6-I^F2JT%C?/K)N8M0,Y2*VC\@MO+
MB7S3'RI!Y!?=R5QVH Z#4_%>BZ7;22R7]O*Z,$\F*9"Y8MMQ@L,8.<Y(Q@^E
M7(]8T]Y+>%[RWBN9T5TMWG3S"",C@$Y_#(]":Y1].NAX2EB6SF\Y]8,I01G<
M5^TYW8]-H!SZ47UI<&TUG2QI]R]_>7WG6\ZPDI@E2KF3&%V@="0>.!S0!UCZ
MQID4[P2:C9I,GWHVG4,O;D9XZU&-?T9E5AJ]@59]@(N4P6].O7D<5S=[IL\F
MA>)T%E*TES?[E41DM*G[OD>H^]^M2:EIDCW'BYDL6;SM,CC@*Q9WL$D^5>.3
MG;P/;VH Z6ZU;3;&=8+O4+2WE<96.:949AG&0"?6B?5]-M;@07&HVD,Q( CD
MF56)/08)SW%<7KR:C<6>J6:VMS'OM$6-+6PWM=GRUYDE(( 4[AM^5N.#T!GN
MM-GET_Q.PL96DGL(4B_<G<Y$1X7C)(/;UH Z^YU*PLIHX;J]MH)9?]6DLJJS
M]N 3S1)J5A%>I927MLET^-L#2J';Z+G)KG(Q]CU#4WU+3+F\%[%!Y:I:F82
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MXR/++,,9]"1G'K4.C6]SICZ7>WME<FWB2[AVI;N[PLTY96V*"V"HQD#N.QH
MZ:VU_3I])34Y+B.UM7D>-7N75 2K,O7..2IQSTJXE]:22Q1I=0-)+'YL:K("
M73^\!W'O7!:987MI;:-<O%J-C;1+=Q[+>V$DMNSS%ERA1S@J,94>G.#S-?Z/
M<7>C6FG:5;Z@EP9)KI;F[41&)6W;ER@ 7>6P$X(!R0,4 =U!<074*S6\T<T3
M9VO&P93@X."/<5)5/27CDTFT,5K):H(E46\B%6BP,;2#Z8Q[]1Q5R@ HHHH
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M #ZZY_X(KW_XS1_PF6E_\^NN?^"*]_\ C- '045S_P#PF6E_\^NN?^"*]_\
MC-'_  F6E_\ /KKG_@BO?_C- '045S__  F6E_\ /KKG_@BO?_C-'_"9:7_S
MZZY_X(KW_P",T =!17/_ /"9:7_SZZY_X(KW_P",T?\ "9:7_P ^NN?^"*]_
M^,T =!17/_\ "9:7_P ^NN?^"*]_^,T?\)EI?_/KKG_@BO?_ (S0!T%%<_\
M\)EI?_/KKG_@BO?_ (S1_P )EI?_ #ZZY_X(KW_XS0!T%%<__P )EI?_ #ZZ
MY_X(KW_XS1_PF6E_\^NN?^"*]_\ C- '045S_P#PF6E_\^NN?^"*]_\ C-'_
M  F6E_\ /KKG_@BO?_C- '045S__  F6E_\ /KKG_@BO?_C-'_"9:7_SZZY_
MX(KW_P",T =!17/_ /"9:7_SZZY_X(KW_P",T?\ "9:7_P ^NN?^"*]_^,T
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M-^'/^1D\7_\ 83B_]([>NDKG/#H(\1^+B1UU*(C_ , [>NCH **** "BBB@
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MYK*N]%MWTVTC_P"$7ENUBMY8HXYIXR\3,1RP+[?FQG>"6'I5:V\/ZO!"NF7
M-RLUW;WDU]Y@P"BIO!!.XL3$,'!!W9)'- ';5S_A[_D.>+/^PK'_ .D5K705
MQ>GZ!9ZKXD\53W$VI(ZZG&@%KJ5Q;KC[';'E8W4$\]<9Z>@H [2BN?\ ^$-T
MO_GZUS_P>WO_ ,>H_P"$-TO_ )^M<_\ ![>__'J .@HKG_\ A#=+_P"?K7/_
M  >WO_QZC_A#=+_Y^M<_\'M[_P#'J .@HKG_ /A#=+_Y^M<_\'M[_P#'J/\
MA#=+_P"?K7/_  >WO_QZ@#H**Y__ (0W2_\ GZUS_P 'M[_\>H_X0W2_^?K7
M/_![>_\ QZ@#H**Y_P#X0W2_^?K7/_![>_\ QZC_ (0W2_\ GZUS_P 'M[_\
M>H Z"BN?_P"$-TO_ )^M<_\ ![>__'J/^$-TO_GZUS_P>WO_ ,>H Z"BN?\
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M Z"BN?\ ^$-TO_GZUS_P>WO_ ,>H_P"$-TO_ )^M<_\ ![>__'J .@HKG_\
MA#=+_P"?K7/_  >WO_QZC_A#=+_Y^M<_\'M[_P#'J .@HKG_ /A#=+_Y^M<_
M\'M[_P#'J/\ A#=+_P"?K7/_  >WO_QZ@#H**Y__ (0W2_\ GZUS_P 'M[_\
M>H_X0W2_^?K7/_![>_\ QZ@#H**Y_P#X0W2_^?K7/_![>_\ QZC_ (0W2_\
MGZUS_P 'M[_\>H Z"BN?_P"$-TO_ )^M<_\ ![>__'J/^$-TO_GZUS_P>WO_
M ,>H 9X?)_X2CQ:,\?;H/_26&NCK@-#\)Z?)XC\3QM<:R%CNX0A76;Q20;>(
M\D2Y;DGDYXXZ "M__A#=+_Y^M<_\'M[_ /'J .@HKG_^$-TO_GZUS_P>WO\
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M#P,&^QVW 587!&,<Y[GCCGM*Y_P]_P ASQ9_V%8__2*UH /MGC#_ * 6A_\
M@YF_^1:/MGC#_H!:'_X.9O\ Y%KH** .?^V>,/\ H!:'_P"#F;_Y%H^V>,/^
M@%H?_@YF_P#D6N@HH Y_[9XP_P"@%H?_ (.9O_D6C[9XP_Z 6A_^#F;_ .1:
MZ"B@#G_MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\ Y%KH** .?^V>,/\
MH!:'_P"#F;_Y%H^V>,/^@%H?_@YF_P#D6N@HH Y_[9XP_P"@%H?_ (.9O_D6
MC[9XP_Z 6A_^#F;_ .1:Z"B@#G_MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.
M9O\ Y%KH** .?^V>,/\ H!:'_P"#F;_Y%H^V>,/^@%H?_@YF_P#D6N@HH Y_
M[9XP_P"@%H?_ (.9O_D6C[9XP_Z 6A_^#F;_ .1:Z"B@#G_MGC#_ * 6A_\
M@YF_^1:/MGC#_H!:'_X.9O\ Y%KH** .?^V>,/\ H!:'_P"#F;_Y%H^V>,/^
M@%H?_@YF_P#D6N@HH Y_[9XP_P"@%H?_ (.9O_D6C[9XP_Z 6A_^#F;_ .1:
MZ"B@#G_MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\ Y%KH** .?^V>,/\
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M ,BUT%% '!Z3=>*AXE\0&/1M&:0RP>8K:M* I\I<8/V8YX]A^/6MS[9XP_Z
M6A_^#F;_ .1:-&_Y&KQ+_P!=;?\ ]$K704 <_P#;/&'_ $ M#_\ !S-_\BT?
M;/&'_0"T/_P<S?\ R+7044 <_P#;/&'_ $ M#_\ !S-_\BT?;/&'_0"T/_P<
MS?\ R+7044 <_P#;/&'_ $ M#_\ !S-_\BT?;/&'_0"T/_P<S?\ R+7044 <
M_P#;/&'_ $ M#_\ !S-_\BT?;/&'_0"T/_P<S?\ R+7044 <_P#;/&'_ $ M
M#_\ !S-_\BT?;/&'_0"T/_P<S?\ R+7044 <_P#;/&'_ $ M#_\ !S-_\BT?
M;/&'_0"T/_P<S?\ R+7044 <_P#;/&'_ $ M#_\ !S-_\BT?;/&'_0"T/_P<
MS?\ R+7044 <_P#;/&'_ $ M#_\ !S-_\BUGV\VL2_$/2_[6L;&UQI5]Y?V2
M\>XW?O;3.=T28[=,YR>F.>PKG[S_ )*'HW_8*O\ _P!&VE '04444 <_>?\
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M++*NX)N.!N;H,9&>"17GMQ\6_&WCK7H+'P!9M;,MIYD\$BPN0P;YFWOP%P5
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M_P#0UZ'_ .#&'_XJC_A._!__ $->A_\ @QA_^*H Z"BN?_X3OP?_ -#7H?\
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M_P!#7H?_ (,8?_BJ .@HKG_^$[\'_P#0UZ'_ .#&'_XJC_A._!__ $->A_\
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M (EEK%D1-)&AE!R0NR,_*<D;B0#@8^@!O:5^T1X8N; RZG9WEE=#>?(C F!
MQC#?+RV3CCL<D<9Y\_M*L-3F(\-[]/VXB'VC;+N]6.",'C@#CU->A7OP9\#W
MLFFE=)%LEBV0D#8$XSG;*3DN/?.>V<<5W%K:6UC:QVMG;Q6]O&,)%"@1%'H
M.!0!\V77C?XL>*WGU_P_;Z@FCV]V1!#:P*V/12 -TN!UX(!].*S[/X5_$,ZK
M9V8N+NU&LVQEOK@R.(X^6)CF*YRV IP>[8[$CZIHH ^=-,^ ?B+5KZZA\2ZR
MT=K9Q^183*_G%QDD$*3\J#).TX.3^->R^#_ 6@^";/R]*LU6Y>-$N+IB6>8@
M<GDG:">=HP/:NFHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110!S^E_\CIX@_ZY6G_H+UT%<_I?_(Z>(/\ KE:?^@O704 %%%%
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M .$>U3_H<]<_[\V7_P CT?\ "/:I_P!#GKG_ 'YLO_D>@#H**Y__ (1[5/\
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M'/7/^_-E_P#(] '045S_ /PCVJ?]#GKG_?FR_P#D>C_A'M4_Z'/7/^_-E_\
M(] '045S_P#PCVJ?]#GKG_?FR_\ D>C_ (1[5/\ H<]<_P"_-E_\CT =!17/
M_P#"/:I_T.>N?]^;+_Y'H_X1[5/^ASUS_OS9?_(] '05S]Y_R4/1O^P5?_\
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M;K2-<,.HW%_:1ZC-':S33M,?*"(5"NQ)9>>#DY'.3G)\]M;B]C\(27$.IZA
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M.HMJUQJ4VH7ZW,7B:"R^SBZD\A8GABWIY6=I&9&/()! QBO4ZY__ (2'5/\
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M\/ZEJ"'4XV,MK);JH/V.V^4^9*ASQGICD<]<=I7/^'O^0YXL_P"PK'_Z16M
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M/^A,US_O]9?_ "17044 <_\ \)#JG_0F:Y_W^LO_ )(H_P"$AU3_ *$S7/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDCG1$::"6-D:,L,CA@,CK@C@XH S_P#A!/!__0J:'_X+H?\ XFC_ (03P?\
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M"&-"@RO'S([<?WO7-7O^$$\'_P#0J:'_ ."Z'_XFM#2]3-^)H9X#;7MNP6>
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M-*7?&W'S!T'_   9Z"KW_"">#_\ H5-#_P#!=#_\35[2]:M]3:2#:T-["/\
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MD8ZD$4 :$(77=,FM-4L6BE1MDT9SMW#D-&W<="".1[&M50%4*,X QR<FEHH
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MF_\ D6BB@ ^V>,/^@%H?_@YF_P#D6C[9XP_Z 6A_^#F;_P"1:** #[9XP_Z
M6A_^#F;_ .1:/MGC#_H!:'_X.9O_ )%HHH /MGC#_H!:'_X.9O\ Y%H^V>,/
M^@%H?_@YF_\ D6BB@ ^V>,/^@%H?_@YF_P#D6C[9XP_Z 6A_^#F;_P"1:**
M#[9XP_Z 6A_^#F;_ .1:/MGC#_H!:'_X.9O_ )%HHH /MGC#_H!:'_X.9O\
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M/MGC#_H!:'_X.9O_ )%HHH /MGC#_H!:'_X.9O\ Y%H^V>,/^@%H?_@YF_\
MD6BB@!EG9Z[=>*;75-4L].M(;6RN+=5M;UYV=I7A;)W1(  (3Z]:*** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
